Chapter 14: Red Blood Cell and Bleeding Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we are not just skimming the surface.

We are wading into the absolute bedrock of internal medicine.

We are opening up chapter 14 of Robin's Basic Pathology.

The Red Blood Cell and Bleeding Disorders chapter.

Yeah, this is, it's a beast of a topic,

but one that is absolutely fundamental to medicine.

It is a total beast.

And honestly, for anyone in the medical field, whether you're a medical student sweating over step one, a nursing student, or even, you know, a resident trying to remember why you order that Coombs test, this is high yield territory.

It really is.

I mean, the blood is the liquid organ that connects literally everything else.

If the blood fails, every other organ system eventually follows suit.

Exactly.

And our mission today is very specific.

We are treating this deep dive like a last minute lecture.

We know who you are out there.

You might have an exam tomorrow or maybe you're on rounds and just need to sound smart.

So we are going to translate the dense high yield text of Robin's into a clear conversational guide.

Right.

We're going to dismantle the vocabulary.

We're going to take terms like microcytic, hemolysis, coagulopathy, and turn them from these dry buzzwords into actual mechanical understandings of how the body breaks.

And we want to walk through the chapter exactly as it's written in the text, preserving that logical flow from the mechanisms to the morphology straight into the clinical presentation.

We've got two massive pillars to climb today.

Pillar one is anemia, basically when you just don't have enough red cells.

And pillar two is bleeding disorders, which is when the system that stops you from bleeding hemostasis, when that fails.

It sounds so simple when you say it like that.

Too little blood or too much bleeding.

But as we'll see, the machinery required to keep your blood liquid, but clottable and oxygenated, but not sludge -like is incredibly complex.

My goal today is to help you understand these not just as

vocabulary words to memorize, but as physical descriptions of physiological failures.

Let's start at the very beginning then.

How does Robbins actually define anemia?

Because I feel like low blood is a bit too simple and lay people off and just assume it means low iron.

Yeah, it's way too simple.

Technically, anemia is defined as a reduction of the total circulating red cell mass below normal limits.

The immediate consequence of that is a reduction in the oxygen carrying capacity of the blood.

Right.

If you can't carry oxygen, you get tissue hypoxia.

Yeah.

The measuring total red cell mass sounds like a really difficult thing to do in a standard clinic.

You can't exactly drain a patient, weigh their cells, and put them back in.

No, no.

That would be highly found upon.

It's totally impractical for day -to -day medicine.

So in practice, we diagnose anemia based on two other numbers that you find in a standard CBC, the hematocrit and the hemoglobin concentration.

The hematocrit is just the ratio of packed red cells to the total blood volume.

Okay, but there is a catch here, right?

Because those numbers are ratios involving volume.

Precisely.

And this is a massive key concept for students.

Since hematocrit and hemoglobin are concentrations, they can be skewed by the plasma volume.

For example, if a patient is retaining a huge amount of fluid,

say they have congestive heart failure or maybe they're pregnant, their plasma volume goes up.

It dilutes the blood.

Exactly.

It dilutes the red cells, making them look anemic on paper when their actual red cell mass might be perfectly normal.

We call that hemodilution.

And the opposite would be true for dehydration, I assume.

Spot on.

If you're severely dehydrated, like a patient with cholera or severe burns,

your plasma volume drops, which concentrates the blood.

That can actually mask an underlying anemia because the numbers look higher than they really are relative to the total mass.

So rule number one for the wards.

Always, always interpret the numbers in the context of the hydration status.

Always.

You have to treat the patient, not just the lab value.

So assuming we've ruled out fluid issues and we have a true anemia, Robbins lays out a roadmap for us.

Where are we going first?

We're going to follow the chapter structure exactly.

We'll start with anemias, breaking them down by cause.

So that's blood loss, increased destruction, which we call hemolysis, and decreased reduction.

Then we'll briefly touch on the opposite problem, polysathemia, where you have way too many red cells.

And finally, we'll switch gears entirely to

bleeding disorders, looking at the vessels, platelets, and the coagulation cascade.

All right.

Let's jump straight into section one, which is classifying anemia.

It seems like the book gives us two ways to look at this problem.

It does.

You can classify by mechanism, which is what we just mentioned, loss, destruction, or production failure.

That's table 14 .1 in the text.

It's basic factory logic.

Either you are losing the product, destroying the product, or the factory itself is broken.

Right.

But clinically, when you're actually looking at a patient's chart, the most useful approach is often morphological, isn't it?

Yes.

Meaning what the cells actually look like under the microscope or to the lab analyzer.

Size and color.

This is where the red cell indices come in.

These are the numbers spit out by the lab machines, and you absolutely have to know what they mean.

Let's decode them.

This is table 14 .2.

The big one, the one everyone looks at first, is the MCV.

The mean cell volume.

This measures the average volume of a red blood cell in femtulators.

This is your first major fork in the road diagnostically.

If the MCV is low, the cells are microcytic or small.

If it's high, they are macrocytic or large.

And if it's normal, they're normacytic.

And Robbins gives us a really solid general rule of thumb for what these sizes imply regarding the underlying problem.

It does, and it's a great mental model.

Generally, microcytic anemias, the small cells, are caused by disorders of hemoglobin synthesis.

Think of the red cell as a literal bag designed specifically to hold hemoglobin.

If you can't begin a hemoglobin filler, the body doesn't bother making the bag bigger.

It stops early.

So iron deficiency and thalassemia, those are synthesis problems leading to small cells.

On the other hand, macrocytic anemias, the big cells, those usually stem from abnormalities that impair the maturation of the erythroid precursors in the bone marrow, right?

Exactly.

Usually it's a DNA synthesis issue.

The cell is getting ready to divide, but the DNA just isn't ready.

Meanwhile, the cytoplasm keeps growing and growing, waiting for the nucleus to catch up so it can split, but it never does properly.

So you end up with these big, clumsy, oversized cells that's classic for B12 and folate deficiency.

Okay, so small usually means a synthesis problem.

Big usually means a maturation problem.

What about the color of the cells?

That's reflected in the MCH, mean cell hemoglobin, and the MCHC, the mean cell hemoglobin concentration.

These tell you how much hemoglobin is actually packed into a given volume of cells.

If it's low, the cells look physically pale under the microscope, which we call hypochromic.

This usually tracks right alongside microcytic anemias.

The cells are small and pale.

And there's one more index that I feel gets overlooked a lot on rounds, the RDW.

Oh, the red cell distribution width.

I love the RDW.

This is the coefficient of variation of red cell volume.

In plain English.

In plain English, it tells you how much the cell sizes vary from one another.

Are they all uniform clones of each other?

Or do you have some tiny ones mixed with some huge ones?

A high RDW means a lot of variation, which we formally call anisocytosis.

It's often the very first clue in early nutritional deficiencies, sometimes shifting even before the MCV changes significantly.

Got it.

So we have our indices down.

Now let's actually apply them.

Section two is anemias of blood loss.

This seems straightforward, but the text makes a huge distinction between bleeding out quickly versus bleeding slowly over month.

It's a massive difference.

Let's talk about acute blood loss first.

Think trauma, a car accident, a GI bleed, a severed artery.

If you lose a huge amount of blood rapidly, say 20 % of your total volume, the immediate threat to your life isn't actually the anemia.

It's shock.

You've lost intravascular volume and you can suffer cardiovascular collapse.

But assuming you survive that initial trauma and your pressure is stabilized, what happens to the blood itself?

This brings us right back to that fluid shift we discussed earlier.

To restore blood volume and keep your blood pressure up, the body shifts fluid from the interstitial spaces, the tissues into the blood vessels.

This dilutes the remaining red cells.

So now you have hemodilution and your hematocrit drops.

It might actually take 24 to 48 hours for the lab numbers to fully reflect the true extents of the blood loss.

And what do the cells look like at this early stage?

Initially, they're completely normocytic and normochromic.

They look totally normal.

There are just fewer of them around.

But, and this is a critical testable point, the bone marrow is going to respond.

The factory wakes up.

Exactly.

The low oxygen levels in the blood trigger the kidneys to release a hormone called erythropoietin or EPO, which stimulates the marrow.

After about five to seven days, you'll see a striking increase in reticulocytes in the peripheral blood.

Reticulocytes are the immature red cells, right?

Yes.

They are basically the teenage red blood cells.

They're slightly larger than mature cells.

And under the microscope, they have this distinct blue -red polychromatophilic cytoplasm.

Polychromatophilic, meaning they love multiple colors.

Right, because they still have some ribosomal RNA strands left over in them, which picks up the blue stain, mixing with the red of the hemoglobin.

So in the recovery phase of acute blood loss, you expect a reticulocyte count to shoot up, maybe to 10 or 15 percent.

And Robbins mentions a little side note here.

You might also see high platelets on the CBC.

Yes, thrombocytosis.

The production of platelets often ramps up right alongside the red cells during that early recovery phase because the growth signaling in the marrow is just generally upregulated across the board.

Okay, that's acute loss.

What about chronic blood loss?

This is a completely beast.

This occurs when the rate of blood loss simply exceeds the marrow's ability to regenerate it.

But more importantly, if you bleed chronically, say from a slow bleeding GI ulcer, colon cancer, or heavy menstruation, you are losing iron.

Every single drop of blood contains iron bound up in the hemoglobin.

Eventually, your body's iron reserves are just completely depleted.

So chronic blood loss essentially morphs into iron deficiency anemia.

Correct.

You really can't separate them clinically.

If you see iron deficiency anemia in an adult male or a post -menopausal female, it is chronic blood loss until proven otherwise.

You have to go looking for the bleed.

And we'll discuss this specific morphology of iron deficiency later, but remember the golden rule.

Chronic bleeding equals iron loss.

Let's move on to section three, hemolytic anemias.

This is where the red cells are being actively destroyed faster than they should be.

Hemolysis literally translates to blood breaking.

Robbins outlines three shared features for all hemolytic anemias, regardless of the specific cause.

First, a shortened red cell lifespan,

so they live less than their normal 120 days.

Second, elevated erythropoietin levels and increased erythropoiesis in the marrow as it frantically tries to compensate.

And third, the accumulation of hemoglobin degradation products in the body.

The breakdown products.

That's where the jaundice comes from, right?

Billy Rubin.

Exactly.

Now, how the cells break really matters.

We classify hemolysis into two main types,

extravascular and intravascular.

Extravascular is by far the most common route.

Extravascular implies it's happening outside the blood vessels.

It means it's happening inside the phagocytes, specifically the macrophages, mostly in the spleen, but also the liver and bone marrow.

Normally, red cells are incredibly flexible.

They have to be to squeeze through the tiny microcirculation.

But if they become stiff or less deformable for any reason, they can't squeeze through the tiny splenic cords of bilros.

They get stuck.

They get stuck in the sieve and the resident macrophages just eat them.

This makes it sound like the spleen is the graveyard for bad red blood cells.

It's the quality control inspector and the executioner all rolled into one.

And because the spleen is working so much overtime eating these cells, it gets bigger.

So the classic clinical triad for extravascular hemolysis is anemia, splenomegaly and jaundice.

What about haptoglobin?

I feel like I always see this on board questions.

Haptoglobin is a plasma protein, and its entire job is to bind free hemoglobin.

Even in extravascular hemolysis, a little bit of hemoglobin escapes from the macrophages during the feeding frenzy and leaks into the blood.

Haptoglobin immediately binds it up.

So on a lab test, you will see a decrease in free plasma haptoglobin levels.

Okay, so that's the relatively quiet destruction in the spleen.

What is intravascular hemolysis?

This is the violent route.

This is when cells literally burst right inside the circulation.

This can be caused by sheer mechanical injury, like a defective artificial heart valve just chopping up cells as they pass, or toxins, parasites like malaria or complement fixation.

And the clinical findings are much more traumatic here.

Oh yes.

You get hemoglobinemia, which is free hemoglobin visibly floating in the blood plasma.

You get hemoglobinuria, which turns the urine red or brown.

And eventually as the kidney tubular cells shed, you get hemocedernuria.

And what happens to our friend haptoglobin in this violent scenario?

It gets absolutely completely depleted very rapidly because there is just so much free hemoglobin floating around.

Also, that unbound free hemoglobin can oxidize into methamoglobin, which is brown.

That's why the patient's urine can look dark red brown, almost like Coca -Cola.

Robbins also points out the general morphology of hemolysis, basically regardless of the cause.

Figure 14 .1 shows this.

What does the bone marrow actually look like?

It looks like a factory in overdrive.

You see marked erythroid hyperplasia, meaning there are tons and tons of immature normal blasts packing the marrow space.

In the peripheral blood, you see that prominent reticulocytosis we talked about.

And because of the massive turnover of humor, you can get pigment gallstones, also called cholothiasis, from all that excess bilirubin being excreted by the liver.

So if you see a young person with gallstones, you should always check them for hemolysis.

Always.

It's a huge red flag.

Alright, let's dig into the specific diseases.

Section 4 covers inherited hemolytic anemias.

The first one is hereditary spherocytosis.

This is a structural problem with the red cell membrane skeleton.

The cell membrane is usually supported from the inside by this complex scaffold of proteins.

In hereditary spherocytosis, or HS, you have an intrinsic genetic defect in one of these tethering proteins, mostly spectrum, ankyrin, band 3, or band 4 .2.

It's usually inherited in an autosomal dominant pattern.

And the result is right in the name, serocytosis.

The cells become actual spheres.

Right.

Robbins shows this beautifully in figure 14 .2.

The vertical interactions between the internal cytoskeleton and the outer lipid bilayer basically fail.

The membrane isn't anchored tightly, so as the cell travels, it sheds little bits of its lipid bilayer in the form of tiny vesicles.

It's just losing pieces of its skin.

Exactly.

And as the cell loses surface area but keeps the exact same internal volume, simple geometry forces the cell to change shape from a nice flexible biconcave disc into a rigid sphere.

And spheres are absolutely not flexible.

So they go to the spleen and they get stuck.

Yep.

They're completely non -deformable.

They get trapped in the spleen at cords and eaten alive by the macrophages.

What are the specific lab clues for HS?

Beside actually seeing the serocytes on the peripheral smear, which look like these dark red perfectly round balls without that normal central pallor, you often see an increased MCHC.

The cells are slightly dehydrated, so the hemoglobin is super concentrated.

And there's a very specific test called the osmotic fragility test.

How does that work?

Well, because there are already spheres, they're at their maximum volume for their surface area.

They're already fully swollen.

If you put them in a hypoconic salt solution, water rushes in and they burst much, much faster than normal biconcave red cells would.

And the clinical presentation for these patients?

The classic triad, anemia splenomegaly jaundice.

But there's a very specific dangerous risk that Robbins highlights, a plastic crises.

If a patient with HS gets infected with Parvovirus B19.

Oh, that's the virus that causes fifth disease in kids.

Right.

That virus specifically infects and kills the red cell progenitors in the bone marrow.

Now, in a normal person, stopping red cell production for a week while fighting a virus isn't a big deal because your red cells live for 120 days.

But in HS, the lifespan of the red cells is already severely shortened down to maybe 10 to 20 days.

So if production stops even briefly, their blood count absolutely crashes.

That's at a plastic crisis.

Wow.

And what's the treatment for HS?

Splenectomy.

If you surgically take out the spleen, you remove the primary trap.

The underlying genetic defect is still there, so the serocytes persist in the blood.

But they aren't being actively destroyed anymore, so the anemia resolves.

However, taking out the spleen leaves the patient at a lifelong increased risk for severe sepsis from encapsulated bacteria like stripped pneumo.

Moving on to an enzyme defect, G6PD deficiency.

This is an X -linked recessive disorder, so it primarily affects males.

G6PD stands for glucose 6 -phosphate dehydrogenase.

It's a critical enzyme in the hexosmonophosphate shunt pathway.

Its entire job in the red cell is to help produce NADPH, which in turn keeps glutathione in its reduced state.

And glutathione is important because...

Glutathione is the red cell's primary antioxidant shield.

It protects the cell from oxidative stress.

Since red cells carry oxygen, they are constantly exposed to oxidants.

So if you don't have G6PD, your red cells basically have no defense against oxidative stress.

Correct.

Under normal, everyday conditions, these patients might be totally fine.

But if they are exposed to a severe trigger -like certain infections, which cause leukocytes to produce free radicals, or specific drugs like antimalarials or sulfonamides, or historically eating Fava beans,

the red cells undergo massive oxidative damage.

And this creates a very specific morphological finding that Robbins shows in figure 14 .5.

Yes, Heinz bodies.

The oxidative stress causes the hemoglobin inside the cell to physically denature and precipitate out of solution.

It clumps together and forms this dark spot attached to the inside of the cell membrane.

That clump is a Heinz body.

You can't see those on a normal smear, right?

Right.

You need a special super -vital stain to see them.

But what you will see on a normal smear happens after that cell passes through the spleen.

As these Heinz body -containing cells try to squeeze through, the splenic macrophages literally try to pluck that rigid Heinz body right out of the membrane.

Resulting in?

Bite cells.

The cell emerges, looking like someone took a literal semicircular bite out of it, like a cookie.

These severely damaged cells are then rapidly destroyed, leading to acute intravascular and extravascular hemolysis.

The patient suddenly gets very anemic, jaundiced, and has dark urine right after exposure to the trigger.

Fascinating.

Now we arrive at section 5, hemoglobinopathies.

We have to talk about sickle cell disease.

This is the absolute classic textbook example of how a tiny genetic change causes massive systemic disease.

It really is.

It all comes down to a single -point mutation in the beta -globin gene.

A glutamate residue is replaced by a valine at the sixth position of the chain.

That one swap turns normal adult hemoglobin HbA into sickle hemoglobin HbS.

And the fundamental problem isn't that HbS can't carry oxygen, right?

It's the shape change when it unloads the oxygen.

Indecisely.

Glutamate is hydrophilic, but valine is hydrophobic.

When HbS is deoxygenated, that hydrophobic valine spot is suddenly exposed to the watery environment of the cell.

To hide from the water, the HbS molecules stick to each other.

They polymerize into these long, rigid rod -like chains.

And these rods physically distort the red cell?

Yes.

As shown in figure 14 .6, they push against the membrane and distort the cell into that classic crescent or sickle shape.

Now initially, this polymerization is completely reversible.

If the cell gets back to the lungs and you add oxygen, the polymers melt back into normal liquid hemoglobin.

But it doesn't stay reversible forever?

No.

With repeated episodes of sickling and un -sickling, the cell membrane takes a beating.

It gets severely damaged.

Calcium rushes into the cell.

Potassium and water rush out.

And the cell becomes permanently dehydrated and irreversibly sickled, even when oxygen is present.

What are the main systemic factors that drive this sickling process in a patient?

Basically anything that slows the blood down or reduces oxygen tension.

Dehydration is a big one because it increases the MCHC, concentrating the HBS so it polymerizes faster.

Low pH or acidosis decreases oxygen affinity infections.

Or just naturally slow transit times in sluggish microvasculature, like in the spleen or bone marrow.

And the clinical consequences of all this are essentially twofold, right?

Hemolysis and microvascular obstruction.

Yes.

The rigid sickle cells simply don't survive long.

They break down, causing chronic severe hemolytic anemia.

But the more dangerous consequence is that these sticky, rigid cells physically clog small blood vessels.

This causes downstream ischemic tissue damage and severe agonizing pain.

Let's look at the morphology.

Figure 14 .7 in the text mentions target cells and howl -jolly bodies on the peripheral smear.

Target cells look exactly like a bullseye.

You see them because the cells are dehydrated, leaving them with excess redundant membrane that pools in the center.

But the howl -jolly bodies are really the crucial finding.

These are small, dark nuclear remnants inside the red cell.

And normally, the spleen removes those remnants.

So seeing them in the blood tells you something very important about the patient's spleen.

Exactly.

It tells you their spleen is dead or not functioning.

Which Robbins illustrates in figures 14 .8 and 14 .9.

Right.

In early childhood, a sickle cell patient has a very enlarged spleen because it's massively congested with sickled cells.

But over the years, the spleen undergoes so much repeated infarction and scarring from those sickled cells, constantly blocking its own vessels, that by adolescence, it just shrinks down to this tiny, useless, fibrotic nubbin.

We call this autisplenectomy.

That is such a vivid, albeit tragic, image.

And clinically, these patients suffer from what we call crises.

Vaso -occlusive crises or pain crises are the most common.

They happen in the bones, lungs, liver, brain, and even the penis, causing priapism.

Then there's the acute chest syndrome, which is particularly dangerous and a major cause of death.

What does that look like?

The patient presents with fever, cough, chest pain, and new lung infiltrates on x -ray.

It's a terrifying, vicious cycle where sluggish flow in the lungs causes hypoxia, which causes more sickling, which blocks more vessels, causing even more hypoxia.

And there are sequestration crises too, mostly in young kids before autisplenectomy happens.

Right, where a massive amount of blood suddenly pools in the spleen, causing rapid, life -threatening hypovolemic shock.

And just like in hereditary spherocytosis, they can also get a plastic crises from parvovirus B19 shutting down the marrow.

Okay, let's contrast sickle cell with thalassemia, which is the other major hemoglobinopathy.

It helps to think of it this way.

Sickle cell is a qualitative defect.

You are making a physically bad mutant hemoglobin.

Thalassemia is a quantitative defect.

You just aren't making enough of the normal hemoglobin.

Specifically, it's a deficient synthesis of either the alpha or the beta globin chain.

And normal adult hemoglobin needs a strict balance of two alpha and two beta chains.

Exactly, it has to be a one -to -one ratio.

Let's take beta thalassemia first.

Because of various point mutations, you can't make enough beta chains.

This causes two huge problems.

One, you simply have low hemoglobin overall, so you get a severe microcytic hypochromic anemia.

And the second problem, the really destructive one.

You have a relative excess of alpha chains.

Because the alpha chains are still being produced at a normal rate, they have no beta partners to pair up with.

These unpaired alpha chains are highly unstable.

They precipitate out and form insoluble inclusions that severely damage the red cell membrane.

So the cells die.

Yes, but they don't just die in the blood.

They die right inside the bone marrow before they are even released.

This leads to massive apoptosis of the precursors, a phenomenon we call ineffective erythropoiesis.

So the marrow is churning out cells, but they...

Before they even reach the blood.

And because the body senses this severe anemia, it thinks it's starving for oxygen.

So the kidneys pump out huge amounts of erythropoietin.

And the bone marrow expands massively trying to keep up.

Which leads to those dramatic skeletal changes shown in figure 14 .12.

Right.

The marrow expands so aggressively that it actually erodes the outer cortex of the bone.

On a lateral skull x -ray, this gives the classic crew cut appearance, where the bone looks like hair standing on end.

It can also cause severe deformities of the facial bones, particularly the maxilla.

There's also a really important iron connection here that students often miss.

Yes.

The ineffective erythropoiesis actually suppresses a liver hormone called hepcidin, likely via a marrow mediator called erythroferone.

And hepcidin usually stops iron absorption, right?

Right.

So with hepcidin suppressed, the gut just continuously absorbs massive amounts of dietary iron.

Even if the patient is never transfused, they can develop fatal iron overload or secondary hemochromatosis simply from their own hyperactive iron absorption.

It destroys their heart and liver.

What about alpha thalassemia?

Alpha thal is completely different genetically.

It's almost always caused by actual gene deletions, not point mutations.

Right.

And importantly, humans have four copies of the alpha gene, two from each parent.

So the severity entirely depends on how many of those four genes are missing.

So it's a spectrum.

A very clear spectrum.

If you lose one, you're a silent carrier.

Lose two, you have alpha thalassemia trait, a mild microcytic anemia.

If you lose three, you get HbH disease.

What is HbH?

Because there are hardly any alpha chains.

The excess beta chains start forming tetramers, four beta chains stuck together.

That's called hemoglobin H.

It causes a moderately severe hemolytic anemia because HbH is useless for oxygen delivery.

It holds onto oxygen way too tightly.

And if you lose all four alpha genes?

That is hydrox fatalis.

In utero, the fetus uses gamma chains instead of beta chains.

With no alpha chains available, the excess gamma chains form tetramers called hemoglobin barts.

Hemoglobin barts binds oxygen so incredibly tightly that it simply will not release it to the fetal tissues at all.

The fetus dies of severe hypoxia and massive fluid retention, which is the hydrox.

It's uniformly fatal without heroic in utero transfusions.

Let's move to section six, acquired hemolytic anemias.

We start with a really unique one, PNH or paroxysmal nocturnal hemoglobinuria.

PNH is fascinating because it's a genetic mutation, but it's an acquired one.

It happens in the hematopoietic stem cells later in life, not something you're born with.

It's a somatic mutation in the PIG gene.

What does PIG actually do?

The PIG gene is responsible for making the GPI anchor.

Think of GPI as a tiny molecular tether that anchors dozens of specific proteins to the surface of the cell membrane.

So if the tether is broken, the proteins just float away.

Exactly.

And two of the most important proteins that rely on that tether are CD55 and CD59.

These are protective proteins.

Their sole job is to sit on the red cell and deactivate complement, stopping the body's immune system from accidentally attacking its own red cells.

So without the GPI anchor, you have no CD55 or CD59.

You have no shields.

Right.

Without those shields, the red cells are incredibly sensitive to spontaneous complement activation.

They get aggressively legionized by the C5B9 membrane attack complex right there inside the blood vessel.

It's classic intravascular hemolysis.

But why is it called nocturnal?

Do they only break at night?

Well, historically, patients noticed their urine was darkest in the morning.

That's because when you sleep, your breathing slows down slightly, you retain a little more CO2, and your blood pH drops just a tiny bit.

That mild acidosis actually increases complement activity, leading to a spike in hemolysis overnight.

But the major risk in TNH isn't just the anemia, right?

No.

The leading cause of death in PNH is actually venous thrombosis.

Clots forming in weird places, like the hepatic vein causing Butchiari syndrome or the cerebral veins.

The prevailing theory is that the complement attack also activates platelets, causing them to clump uncontrollably.

And how do you diagnose PNH?

Figure 14 .13 shows a scatterplot.

That's flow cytometry.

You pass the patient's blood cells through a laser to see what proteins they have.

In PNH, you will literally see a distinct population of cells that are completely negative for CD55 and CD59.

Next up, immunohemolytic anemias.

This is where your own antibodies start attacking your red cells.

We classify these by the temperature at which the culprit antibody is most active, warm versus cold.

Let's do warm antibody type first.

This is usually driven by an IgG antibody.

It's called warm because it binds best to the red cells at 37 degrees Celsius, normal body temperature.

The IgG coats the red cell, a process called opsonization.

And then what happens?

As that coated red cell passes through the spleen, the macrophages recognize the IgG.

But instead of swallowing the whole cell, they often just take little nibbles out of the membrane.

This loss of membrane forces the cell into a spherocyte shape, which then gets fully destroyed on its next pass through the spleen.

It's mainly extravascular hemolysis.

And the diagnostic test is the Coombs test, right?

Specifically, the direct Coombs test or direct anti -globulin test.

It detects if there are actual IgG antibodies physically stuck to the surface of the patient's red cells.

Warm autoimmune hemolysis can be idiopathic or tied to things like lupus or certain drugs.

And what about cold agglutinin type?

This one is usually driven by an IgM antibody.

It binds best at lower temperatures like 0 to 4 degrees.

So it happens in the cool peripheral extremities, the tips of your fingers, your toes, your ears.

And IgM is a huge molecule.

It's massive.

It's a pentamer.

So when it binds to red cells in those cool capillaries, it cross -links them, causing them to physically clump together or agglutinate.

This sludges the blood flow, leading to extreme pallor or cyanosis in the fingers, which is Raynaud phenomenon.

But they don't break in the fingers, do they?

Usually not.

When the blood circulates back to the warm central core of the body, the IgM actually detaches and falls off.

But, and this is the trick, while it was attached, it often activated the complement cascade.

So the complement proteins are left behind in the cell, leading to its eventual destruction by macrophages in the liver or sometimes direct intravascular lysis.

Finally, in this hemolytic section, we have trauma to red cells.

This is pure mechanical destruction.

Think of a defective, really tight artificial heart valve physically slamming shut -on cells or microthrombi in tiny vessels, essentially acting like cheese wire, chopping up the red cells as they get forced past.

And this gives us a very specific morphological finding on the blood smear, figure 14 .14.

Schistocytes.

Fragmented torn up red blood cells.

They can look like little helmets or bur cells or triangles and literally looks like someone put the red cells in a blender.

Alright, deep breath.

We are moving to section 7.

Anemias of diminished erythropoiesis.

This is the third major mechanism.

We aren't losing them, we aren't destroying them, we just aren't making them.

Let's start with megaloblastic anemia.

This is caused by a deficiency of either vitamin B12 or folate.

Both of these vitamins are absolutely essential for making thymidine, which is a key building block for DNA synthesis.

So if you don't have them, your DNA production stalls.

Exactly.

The cell is trying to divide, so the nucleus needs to double its DNA, but it can't.

It matures far too slowly.

But meanwhile, the cytoplasm, which relies on RNA and protein synthesis, not DNA,

it matures at a perfectly normal, rapid rate.

This is what Robbins calls nuclear cytoplasmic asynchrony.

Yes, that's the exact term.

The cell just keeps growing larger and larger while the nucleus lags behind.

Let's talk morphology.

What do we see in the peripheral blood in figure 14 .1p?

The hallmark is macroovalocytes.

They aren't just big macrocytic cells, they're actually physically egg -shaped or oval.

But the other massive diagnostic clue isn't even a red cell, it's the neutrophils.

The hypersegmented neutrophils.

Right, normal neutrophils have maybe three or four lobes in their nucleus.

In megaloblasting anemia, you see neutrophils with five, six, sometimes even more lobes.

That is an absolute dead giveaway.

And what does the marrow look like in figure 14 .1p?

Packed, but dysfunctional.

You see these giant abnormal precursors called megaloblasts.

Their nuclear chromatin looks weirdly delicate and sieve -like, almost like lace, because it hasn't condensed properly due to the DNA synthesis failure.

Now, how do we clinically tell a B12 deficiency and a folate deficiency apart?

Because the blood looks identical.

The major distinguishing factor is neurologic.

B12 deficiency, which is often caused by pernicious anemia, an autoimmune attack on the parietal cells or intrinsic factor in the stomach B12 deficiency causes severe demyelination of the spinal cord.

It fries the nerves, causing numbness, tingling, and gait abnormalities.

And folate deficiency.

Folate deficiency causes the exact same anemia, but zero neurologic symptoms.

It's often seen in people with very poor diets, or chronic alcoholism.

You must differentiate them, because if you treat a B12 deficient patient with folate, you will fix the anemia, but their spinal cord will continue to irreversibly degenerate.

Terrifying.

Moving on to the most common anemia worldwide,

iron deficiency anemia.

This is the classic, microcytic, hypochromic anemia.

As we discussed earlier, in the developed world, this is usually due to chronic, hidden bleeding, like a GI tumor or heavy menses.

In the developing world, dietary insufficiency, or hookworm, is more common.

And the mechanism is simple.

Without iron, you literally cannot assemble hemoglobin.

Right, and without hemoglobin filler, the cells are small, microcytic, and completely washed out, and pale hypochromic.

Looking at figure 14 .22, the normal central zone of power in a red cell usually takes up about a third of the diameter.

In iron deficiency, it's hugely expanded.

Only a thin rim of pink hemoglobin is left at the edge.

And there are these weird shaped cells called pencil cells.

Yes, elongated, skinny red cells that literally look like pencils.

Another definitive diagnostic finding is in the bone marrow.

If you stain it with Prussian blue, which highlights iron, a normal marrow has plenty of iron stored in macrophages.

An iron deficient marrow has absolutely zero stainable iron.

The stores are bone dry.

The clinical symptoms can be pretty odd, right?

Yes, the craving to chew or eat non -food items.

Eating dirt, clay, or raw flour.

Or pygophagia, which is the compulsive craving to chew ice.

They can also get spooning of the fingernails, called coelonechia.

What about anemia of chronic inflammation, also called anemia of chronic disease?

We see this in chronically hospitalized patients constantly.

This is an immune -driven response.

In any chronic inflammatory state like rheumatoid arthritis, chronic infections, or cancer, the immune system releases inflammatory cytokines.

Particularly interleukin -6.

IL -6 specifically tells the liver to ramp up production of our old friend, hepcidin.

Hepcidin, the iron regulator.

Exactly.

But in this case, hepcidin's main effect is to block the transfer of iron from the storage macrophages over to the red cell precursors.

The body essentially locks the iron away in a vault.

Why does the body do that?

It's an evolutionary defense mechanism.

Many bacteria require free iron to grow and replicate.

By sequestering the iron in macrophages, the body's trying to starve the invading pathogen.

But the unfortunate collateral damage is that the bone marrow is also starved of iron, leading to a mild anemia, even though total body iron stores are perfectly normal or even high.

Last one in this group.

A plastic anemia.

This is utter stem cell failure.

Usually it's an autoimmune T cell attack on the multipotent stem cells, or sometimes from drug or chemical exposures.

The stem cells are simply wiped out.

What does the marrow look like in figure 14 .24?

Imagine you're looking at a bone marrow biopsy under the microscope.

Normally it's this incredibly busy, packed city of hematopoietic cells.

But in figure 14 .24, it's just a ghost town.

It's almost entirely composed of these large, empty -looking fat cells, adipocytes.

Just a vast sea of fat, with barely any red or white cell precursors left.

If you try to aspirate it with a needle, you get a dry tap.

And because it's a multipotent stem cell failure, it doesn't just affect red cells.

Right, the patient has severe pancidipenia.

That means profound anemia, neutropenia, making them horribly susceptible to infections, and thrombocytopenia causing bleeding.

Notably, there is no splenomegaly.

If the spleen is huge, it's not pure plastic anemia.

Okay, we've got to touch on section eight quickly.

Polycythemia.

Having way too many red cells.

We distinguish relative from absolute.

Relative polycythemia is just hemoconcentration.

Severe dehydration.

The red cell mass is actually normal, but the plasma volume crashed, so the hematocrit looks artificially high.

An absolute polycythemia.

That's a true physical increase in total red cell mass.

We split that into primary and secondary.

Primary is polycythemia vera, which is a myeloproliferative neoplasm.

It's almost always driven by a JAK2 mutation.

The bone marrow just autonomously pumps out red cells completely independent of any normal regulatory signals.

So what are the erythropoietin levels like in polycythemia vera?

Very low.

The kidneys sense all this extra oxygen and shut down EPO production entirely, but the mutated marrow doesn't care.

It keeps pumping them out.

And secondary polycythemia.

That's when the body actually needs more oxygen, so EPO levels are appropriately high.

Like in chronic lung disease, living at high altitude or psychotic congenital heart disease.

Or sometimes it's inappropriate, like an EPO secreting tumor.

Most commonly a renal cell carcinoma.

Okay, take a deep breath.

We are switching gears entirely.

Section nine, bleeding disorders.

We are moving from the red cells to the hemostatic system.

Normal hemostasis requires a tightly choreographed dance between three elements.

The vessel wall, the platelets, and the coagulation cascade.

Abnormal bleeding can stem from a failure in any of those three.

Vessel wall abnormalities seem to be the mildest group of the three.

Generally, yes.

They usually just present a small petechiae or a propyra in the skin.

Things like scurvy, which is vitamin C deficiency leading to weak collagen support around vessels.

Or Hinoxinline purpura, an immune complex vasculitis.

Or hereditary hemorrhagic thalangiasia, where patients have these dilated, incredibly thin -walled torturous vessels that bleed constantly, especially manifesting as severe nosebleeds.

Let's focus on the platelets, thrombocytopenia, or low platelet count.

A normal count is 150 ,000 to 450 ,000 per microliter.

But clinically, you usually don't see spontaneous bleeding till it drops dangerously low, below 20 ,000 to 50 ,000.

Talk to me about ITP, chronic immune thrombocytopenic purpura.

This is an autoimmune disorder.

Autoantibodies form against very specific platelet membrane glycoproteins, primarily GPI by I or GPI by X.

The platelets function fine, but they are coded in antibodies.

And the spleen strikes again.

Yep, the spleen acts as the executioner again.

The splenic macrophages recognize those opsonized platelets and gobble them up.

But interestingly, the spleen size is usually completely normal on physical exam.

Yes, that is a huge diagnostic clinical pearl.

In ITP, even though the spleen is destroying the platelets, it doesn't generally get massive.

If you feel a huge spleen on exam in the patient with low platelets, it's probably not ITP.

You should be thinking about portal hypertension or leukemia.

And in the marrow of an ITP patient, you'll see a massive increase in megakaryocytes, frantically trying to replace the destroyed platelets.

Now, what about the thrombotic

microangiopathies?

TTP and HUS, these are incredibly high yield for exams.

They are.

They share a lot of common features, both present with thrombocytopenia,

microangiopathic hemolytic anemia, that's the schistocytes we talked about, and renal failure.

They both feature the widespread formation of tiny hyaline thrombi in the microcirculation, but the underlying triggers are totally different.

Let's do TTP first, thrombotic thrombocytopenic purpura.

TTP is caused by a deficiency in a specific plasma enzyme called Adam T1013.

Think of Adam T13 as a pair of molecular scissors.

Its entire job is to patrol the blood and chop up overly large, ultra -long multi -meres of von Willebrand factor.

And if you don't have those scissors?

You get these huge, incredibly sticky VWS multi -meres floating around.

They snag and activate platelets inappropriately, forming micro -thrombi all over the body.

This consumes all your free platelets causing thrombocytopenia, and those physical clots shear the red cells, causing the anemia.

TTP patients classically present as adults with the pentad.

Fever, anemia, thrombocytopenia, renal issues, and incredibly prominent central nervous system symptoms like confusion or seizures.

And HUS hemolytic uremic syndrome.

The classic typical form of HUS is caused by an infection, specifically a Shiga -like toxin from E.

coli 0157H7.

Usually it's a kid who ate an undercooked hamburger and presents with severe bloody diarrhea.

How does the toxin cause clots?

The Shiga toxin gets absorbed from the gut and directly damages the endothelial cells, particularly in the kidneys.

This massive endothelial injury triggers platelet activation and microthrombie formation.

In HUS, acute renal failure is the massively dominant overriding clinical symptom, whereas CNS symptoms are less common.

What if the platelet count is totally normal, but the patient is still bleeding like crazy defective platelet function?

There are two major inherited ones you have to know, and they map perfectly to the platelet glycoproteins we just mentioned.

First is Bernard -Soullier syndrome.

This is a genetic defect in GPI.

Which does what?

GPI is the receptor that allows the platelet to adhere or stick to von Willebrand factor on the damaged vessel wall.

It's the anchor.

No anchor, no adhesion.

You also notably see unusually large platelets on the smear.

And the second one, Glansman thrombesthenia.

This is a defect in GPI -BIA.

This is the receptor that allows platelets to bind to fibrinogen, which physically links multiple platelets together.

So they can adhere to the wall fine, but they absolutely cannot aggregate or clump to each other to form a plug.

And the most common acquired cause of platelet dysfunction?

Aspirin.

Plain old aspirin.

It irreversibly inhibits the cyclooxygenase enzyme, completely blocking the platelets ability to produce thromboxane A2, which is a huge required signal for aggregation.

All right, section 10.

Bleeding disorders involving the coagulation factors.

Let's hit the famous ones.

The hemophilias.

Hemophilia A is a severe deficiency of factor 8.

Hemophilia B, also called Christmas disease, is a deficiency of factor niax.

They are both X -linked recessive disorders, so they almost exclusively affect males.

And clinically, can you tell them apart?

Not without a specific factor assay.

Clinically, they look totally identical.

The hallmark is severe bleeding into the deep joints, which we call haemothorosis, and massive soft tissue hematomas after even minor trauma.

And what do their lab tests look like?

Because factor 8 and niax are both crucial components of the intrinsic coagulation pathway, their PTT will be drastically prolonged.

But their PT, which measures the extra neck pathway, will be totally normal.

But the most common inherited bleeding disorder in the world actually isn't hemophilia, is it?

No, it's von Willebrand disease.

This is usually autosomal dominant.

It's a defect in either the amount or the quality of von Willebrand factor.

And VWF has two distinct jobs which complicates things.

Exactly.

Its first job is to act as the sticky tape that helps platelets adhere to the subendothelium.

So if you lack it, you get platelet -like bleeding problems.

Frequent nosebleeds, heavy menstrual bleeding, new causal oozing.

And its second job.

It acts as the carrier protein for factor 8 in the blood.

It physically stabilizes factor 8 and stops it from being degraded.

So if you are severely deficient in VWF, your factor 8 level also drops, which can give you a prolonged PTT in addition to prolonged bleeding times.

Finally, we reach the absolute disaster scenario on the wards.

DIC.

Disseminated Intravascular Coagulation.

DIC is terrifying.

It is a massive thrombo -hemorrhagic disorder.

It's a complete paradox.

It starts with systemic, totally uncontrolled widespread activation of the coagulation cascade.

Your body starts forming tiny microclots everywhere in all the tiny vessels of your organs.

Which leads to two massive parallel disasters.

Right.

Consequence number one.

That widespread fibrin deposition physically blocks blood flow.

Causing severe ischemic damage to the brain, the lungs, the kidneys.

And those fibrin strands act like a net that chops up red cells.

Causing microangiopathic hemolytic anemia.

And the second disaster.

Because you just inappropriately triggered clotting everywhere, you have completely used up all your platelets and all your coagulation factors making these useless destructive microclots.

So consequence number two is that you now bleed uncontrollably from absolutely everywhere else.

It's a consumption coagulopathy.

What actually triggers this nightmare?

Huge systemic insults.

Overwhelming gram -negative sepsis is a classic one.

Massive trauma.

Severe obstetric complications like placental abruption or retained dead fetus which release huge amounts of tissue factor into the blood.

Or certain malignancies especially acute promyocytic leukemia or mucins accreting adenocarcinomas.

And the morphology and autopsy.

You literally see thrombie choking the microvasculature everywhere.

In the brain, the heart.

In the kidneys it causes bilateral renal cortical necrosis.

In the lungs, it causes high line membranes.

And in the adrenal glands the massive bleeding can completely destroy them which is called Waterhouse -Friedrichsen syndrome.

Wow.

Okay, section 11, the final section.

Complications of transfusion.

We'll touch on this briefly.

You can get allergic reactions which are often triggered if the patient is IgA deficient and they receive blood containing normal IgA.

You can get acute hemolytic reactions if there's a catastrophic ABO mismatch.

But the big scary respiratory one is Chiralei.

Transfusion -related acute lung injury.

Yes.

It's an immune reaction where antibodies in the donor plasma actually activate neutrophils residing in the patient's lungs.

It causes massive sudden pulmonary edema and respiratory failure shortly after the transfusion.

Well, we do it.

We have covered the entire lifespan of the red cell, its violent destruction, its lack of production and the total failure of the clotting system.

It really all comes down to one word.

Balance.

How so?

Think about the entire system we just reviewed.

The hematopoietic system is constantly walking an incredibly thin, dangerous tightrope.

On one side, you absolutely need enough red cell production to carry life -sustaining oxygen, but not so much that the blood literally turns to sludge like in polycythemia.

Right.

And you need your platelets and factors to be able to clot instantly to stop you from bleeding to death from a simple paper cut.

But you can't let them clot so aggressively that you infarct your own organs like in DIC or TTP.

It's amazing how fragile that balance actually is when you look at the molecular level.

It truly is.

Think of sickle cell.

A single tiny amino acid chain swapping a glutamate for a vellin out of hundreds of amino acids can turn this beautiful, life -giving fluid into a rigid crystalline mechanism of extreme pain and organ destruction.

Or just missing a single enzyme like Adamtease -13 can cause your entire microvasculature to clot off completely.

That is a deeply sobering, provocative thought to end on.

The body is incredibly resilient, but the underlying machinery is just so, so precise and so vulnerable.

Thank you so much for breaking this absolute behemoth of a chapter down with us.

To our listeners out there, we really hope this cleared up the fog around anemia and bleeding disorders for your exams and your rotations.

Keep studying.

Keep looking at the smears and keep asking questions on the wards.

This has been a deep dive into Robin's Chapter 14.

From the Last Minute Lecture Team, thank you so much for listening.

See you in the next deep dive.